Maulik G. Shah, MD, FACC, FSCAI

Executive Director, HonorHealth Cardiovascular Center of Excellence

Chief, Complex Interdisciplinary Medicine

Dr. Shah is an interventional cardiologist and co-founder of Atria Heart. He earned his medical degree from the University of California, San Francisco and completed his interventional and general cardiology training at Stanford University. Dr. Shah also trained in internal medicine at Stanford and received its highest recognition as chief resident.

He is board certified in several areas, including cardiology, interventional cardiology, nuclear cardiology and internal medicine.

Dr. Shah was one of the first cardiologists in Arizona to perform transcatheter aortic valve replacement (TAVR). He also specializes in complex coronary stenting and radial heart catheterization. Dr. Shah is a compassionate and active clinician with special interests in coronary disease, congestive heart failure, structural heart disease, preventive cardiology, general cardiology, South Asian heart disease, and women’s cardiovascular health.

Throughout his training and career, Dr. Shah has been involved in research at Stanford University, the National Institutes of Health, and the World Health Organization. He is widely published in medical journals and has presented at national conferences of the American Heart Association and American College of Cardiology.

David G. Rizik, MD, MSCAI, FACC

Chief, Complex Interventional Cardiology

HonorHealth Chief Scientific Officer and Director of Structural and Coronary Interventions

An interventional cardiologist, Dr. Rizik is the founder and medical director of the HonorHealth Heart Group’s Shea location in Scottsdale, where he has practiced for more than 30 years. Dr. Rizik is board certified in interventional cardiology, cardiovascular diseases and internal medicine.

He earned his undergraduate degrees in pre-med from the University of Michigan and Michigan State University and his medical doctorate from St. Louis University. Dr. Rizik completed residencies at Sinai Hospital in Detroit and Barnes Hospital/Washington University in St. Louis. He returned to Michigan to complete fellowships in cardiovascular disease and interventional cardiology at William Beaumont Hospital in Royal Oaks, Michigan.

Dr. Rizik is a distinguished researcher in interventional cardiology and structural heart disease. He has published more than 100 manuscripts and book chapters on coronary artery disease and its treatment. Dr. Rizik has conducted numerous live cases and educational symposia throughout the world. Over the past several years, he has traveled extensively in Europe and the Asia-Pacific as an instructor in interventional cardiology. In addition to being a worldwide leader in coronary intervention, Dr. Rizik specializes in structural heart procedures, including transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair.

Rahul N. Doshi, MD

Chief, Complex Arrhythmia Services

Dr. Doshi is a nationally recognized leader in the field of electrophysiology and recently served as the Director of Electrophysiology at the University of Southern California. He attended the University of California, Los Angeles (UCLA) for his undergraduate education and Stanford University for medical school. Dr. Doshi subsequently completed his internal medicine residency at UCLA and was selected as chief resident. He completed cardiology and electrophysiology fellowships at Cedars Sinai Medical Center in Los Angeles.

An outstanding clinician, Dr. Doshi also has a prolific background in clinical research. He has authored publications in several prestigious journals including the New England Journal of Medicine, Circulation and the Journal of American College of Cardiology (JACC). Dr. Doshi serves on the editorial boards of several publications and societies including the Heart Rhythm Society, JACC Clinical Electrophysiology and European Society of Cardiology. He also serves on scientific advisory boards of several cardiovascular device companies. 

Dr. Doshi is actively involved in the advancement of clinical care and research in diverse areas within cardiology, including therapies for atrial fibrillation, stroke prevention, device therapy for heart failure and ablation for ventricular tachycardia.

Dr. Doshi will be instrumental in developing our Atrial Fibrillation Center of Excellence and lead the way for HonorHealth to be the premier destination for the treatment of all complexities of cardiovascular disease and arrhythmia services.